Lauren Houston1, Yasmine Probst2, Allison Martin3. 1. School of Medicine, Faculty of Science, Medicine, and Health, University of Wollongong, Wollongong, NSW 2522, Australia; Illawarra Health and Medical Research Institute, University of Wollongong, NSW 2522, Australia. Electronic address: lah993@uowmail.edu.au. 2. School of Medicine, Faculty of Science, Medicine, and Health, University of Wollongong, Wollongong, NSW 2522, Australia; Illawarra Health and Medical Research Institute, University of Wollongong, NSW 2522, Australia. Electronic address: yasmine@uow.edu.au. 3. School of Medicine, Faculty of Science, Medicine, and Health, University of Wollongong, Wollongong, NSW 2522, Australia; Illawarra Health and Medical Research Institute, University of Wollongong, NSW 2522, Australia. Electronic address: allisonh@uow.edu.au.
Abstract
INTRODUCTION: Data audits within clinical settings are extensively used as a major strategy to identify errors, monitor study operations and ensure high-quality data. However, clinical trial guidelines are non-specific in regards to recommended frequency, timing and nature of data audits. The absence of a well-defined data quality definition and method to measure error undermines the reliability of data quality assessment. This review aimed to assess the variability of source data verification (SDV) auditing methods to monitor data quality in a clinical research setting. MATERIAL AND METHODS: The scientific databases MEDLINE, Scopus and Science Direct were searched for English language publications, with no date limits applied. Studies were considered if they included data from a clinical trial or clinical research setting and measured and/or reported data quality using a SDV auditing method. RESULTS: In total 15 publications were included. The nature and extent of SDV audit methods in the articles varied widely, depending upon the complexity of the source document, type of study, variables measured (primary or secondary), data audit proportion (3-100%) and collection frequency (6-24 months). Methods for coding, classifying and calculating error were also inconsistent. Transcription errors and inexperienced personnel were the main source of reported error. Repeated SDV audits using the same dataset demonstrated ∼ 40% improvement in data accuracy and completeness over time. No description was given in regards to what determines poor data quality in clinical trials. CONCLUSIONS: A wide range of SDV auditing methods are reported in the published literature though no uniform SDV auditing method could be determined for "best practice" in clinical trials. Published audit methodology articles are warranted for the development of a standardised SDV auditing method to monitor data quality in clinical research settings.
INTRODUCTION: Data audits within clinical settings are extensively used as a major strategy to identify errors, monitor study operations and ensure high-quality data. However, clinical trial guidelines are non-specific in regards to recommended frequency, timing and nature of data audits. The absence of a well-defined data quality definition and method to measure error undermines the reliability of data quality assessment. This review aimed to assess the variability of source data verification (SDV) auditing methods to monitor data quality in a clinical research setting. MATERIAL AND METHODS: The scientific databases MEDLINE, Scopus and Science Direct were searched for English language publications, with no date limits applied. Studies were considered if they included data from a clinical trial or clinical research setting and measured and/or reported data quality using a SDV auditing method. RESULTS: In total 15 publications were included. The nature and extent of SDV audit methods in the articles varied widely, depending upon the complexity of the source document, type of study, variables measured (primary or secondary), data audit proportion (3-100%) and collection frequency (6-24 months). Methods for coding, classifying and calculating error were also inconsistent. Transcription errors and inexperienced personnel were the main source of reported error. Repeated SDV audits using the same dataset demonstrated ∼ 40% improvement in data accuracy and completeness over time. No description was given in regards to what determines poor data quality in clinical trials. CONCLUSIONS: A wide range of SDV auditing methods are reported in the published literature though no uniform SDV auditing method could be determined for "best practice" in clinical trials. Published audit methodology articles are warranted for the development of a standardised SDV auditing method to monitor data quality in clinical research settings.
Authors: Sarah C Lotspeich; Mark J Giganti; Marcelle Maia; Renalice Vieira; Daisy Maria Machado; Regina Célia Succi; Sayonara Ribeiro; Mario Sergio Pereira; Maria Fernanda Rodriguez; Gaetane Julmiste; Marco Tulio Luque; Yanink Caro-Vega; Fernando Mejia; Bryan E Shepherd; Catherine C McGowan; Stephany N Duda Journal: J Clin Transl Sci Date: 2019-12-26
Authors: Renate Le Marsney; Tara Williams; Kerry Johnson; Shane George; Kristen S Gibbons Journal: BMC Med Res Methodol Date: 2022-03-21 Impact factor: 4.615
Authors: Lisa Lindner; Anja Weiß; Andreas Reich; Siegfried Kindler; Frank Behrens; Jürgen Braun; Joachim Listing; Georg Schett; Joachim Sieper; Anja Strangfeld; Anne C Regierer Journal: Arthritis Res Ther Date: 2021-07-07 Impact factor: 5.156
Authors: Mark J Giganti; Bryan E Shepherd; Yanink Caro-Vega; Paula M Luz; Peter F Rebeiro; Marcelle Maia; Gaetane Julmiste; Claudia Cortes; Catherine C McGowan; Stephany N Duda Journal: BMC Public Health Date: 2019-12-30 Impact factor: 3.295